Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.24.1.1.u2
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2024
STOCK-BASED COMPENSATION  
Summary of the expense for stock-based compensation related to stock option grants

Three Months Ended

March 31, 

    

2024

    

2023

Employee and director stock option grants:

 

  

 

  

Research and development

$

68,776

$

66,195

General and administrative

 

385,587

 

342,011

Total stock-based compensation

$

454,363

$

408,206